Emilia Ip

1.2k total citations
14 papers, 958 citations indexed

About

Emilia Ip is a scholar working on Oncology, Genetics and Molecular Biology. According to data from OpenAlex, Emilia Ip has authored 14 papers receiving a total of 958 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 5 papers in Genetics and 3 papers in Molecular Biology. Recurrent topics in Emilia Ip's work include BRCA gene mutations in cancer (5 papers), Liver Disease Diagnosis and Treatment (3 papers) and Colorectal Cancer Surgical Treatments (3 papers). Emilia Ip is often cited by papers focused on BRCA gene mutations in cancer (5 papers), Liver Disease Diagnosis and Treatment (3 papers) and Colorectal Cancer Surgical Treatments (3 papers). Emilia Ip collaborates with scholars based in Australia, South Africa and Belgium. Emilia Ip's co-authors include Pauline de la Μ. Hall, Isabelle Leclercq, Graham Robertson, Geoffrey C. Farrell, Richard Kirsch, Geoff Farrell, Jun Yu, Aileen Dela Peňa, Jing Hou and Annabel Goodwin and has published in prestigious journals such as Journal of Clinical Oncology, Hepatology and Journal of Medical Genetics.

In The Last Decade

Emilia Ip

13 papers receiving 940 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Emilia Ip Australia	7	668	386	243	163	134	14	958
I. Pierantonelli Italy	10	609 0.9×	267 0.7×	219 0.9×	196 1.2×	156 1.2×	15	836
Ryoko Yada Japan	9	603 0.9×	341 0.9×	295 1.2×	114 0.7×	170 1.3×	13	903
Ashwani Kapoor United States	5	536 0.8×	213 0.6×	229 0.9×	161 1.0×	96 0.7×	6	782
M Rosselli Argentina	10	790 1.2×	260 0.7×	419 1.7×	161 1.0×	148 1.1×	10	1.0k
Frank Jankowiak Germany	5	720 1.1×	399 1.0×	321 1.3×	108 0.7×	299 2.2×	6	1.0k
Mulugeta Seneshaw United States	8	500 0.7×	237 0.6×	194 0.8×	136 0.8×	123 0.9×	16	720
M Pérez-Carreras Spain	8	927 1.4×	401 1.0×	400 1.6×	205 1.3×	284 2.1×	21	1.2k
Rocío Gallego‐Durán Spain	16	637 1.0×	276 0.7×	225 0.9×	237 1.5×	135 1.0×	50	940
Yin-xiong Li China	7	759 1.1×	255 0.7×	385 1.6×	162 1.0×	127 0.9×	14	969
Natalia Nuño‐Lámbarri Mexico	17	408 0.6×	275 0.7×	149 0.6×	153 0.9×	153 1.1×	46	815

Countries citing papers authored by Emilia Ip

Since Specialization

Citations

This map shows the geographic impact of Emilia Ip's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emilia Ip with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emilia Ip more than expected).

Fields of papers citing papers by Emilia Ip

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emilia Ip. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emilia Ip. The network helps show where Emilia Ip may publish in the future.

Co-authorship network of co-authors of Emilia Ip

This figure shows the co-authorship network connecting the top 25 collaborators of Emilia Ip. A scholar is included among the top collaborators of Emilia Ip based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emilia Ip. Emilia Ip is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Buchanan, Daniel D., Peter Georgeson, Jihoon E. Joo, et al.. (2025). The germline POLD1 c.1420 C > A (p.Leu474Ile) variant segregates with endometrial cancer, colorectal cancer and colonic polyps demonstrating hypermutation and defective POLD1 mutational signatures. Familial Cancer. 24(4). 82–82.

Lim, Stephanie, Wei Chua, Weng Ng, et al.. (2023). Circulating Tumour Cell Associated MicroRNA Profiles Change during Chemoradiation and Are Predictive of Response in Locally Advanced Rectal Cancer. Cancers. 15(16). 4184–4184. 1 indexed citations

Young, Alison L., et al.. (2023). An Australian mainstream genetic testing program: Clinicians views about current and future practices. Asia-Pacific Journal of Clinical Oncology. 20(1). 119–127. 1 indexed citations

Ip, Emilia, et al.. (2022). Evaluation of a mainstream genetic testing program for women with ovarian or breast cancer. Asia-Pacific Journal of Clinical Oncology. 18(5). e414–e419. 4 indexed citations

Ip, Emilia, Catriona M. McNeil, Peter Grimison, et al.. (2021). Catastrophic chemotherapy toxicity leading to diagnosis of Fanconi anaemia due to FANCD1/BRCA2 during adulthood: description of an emerging phenotype. Journal of Medical Genetics. 59(9). 912–915. 2 indexed citations

Goodwin, Annabel, Emilia Ip, Anthony Linton, et al.. (2020). Evaluation of a mainstream model of genetic testing for men with prostate cancer.. Journal of Clinical Oncology. 38(15_suppl). 1521–1521. 7 indexed citations

Goodwin, Annabel, Emilia Ip, Anthony Linton, et al.. (2020). Evaluation of a Mainstream Model of Genetic Testing for Men With Prostate Cancer. JCO Oncology Practice. 17(2). e204–e216. 36 indexed citations

Lin, Michael, Trang Thanh Pham, Shanley Chong, et al.. (2019). Prognostic utility of serial 18F-FDG-PET/CT in patients with locally advanced rectal cancer who underwent tri-modality treatment. British Journal of Radiology. 93(1105). 20190455–20190455. 8 indexed citations

Lim, Stephanie, Emilia Ip, Weng Ng, et al.. (2019). Health-Related Quality of Life during Chemoradiation in Locally Advanced Rectal Cancer: Impacts and Ethnic Disparities. Cancers. 11(9). 1263–1263. 6 indexed citations

10.

Lim, Stephanie, Emilia Ip, Wei Chua, et al.. (2017). Serum microRNA expression during neoadjuvant chemoradiation for rectal cancer.. Journal of Clinical Oncology. 35(15_suppl). e15081–e15081. 5 indexed citations

11.

Ip, Emilia, et al.. (2016). Use of palliative chemotherapy in patients aged 80 years and over with incurable cancer: experience at three Sydney cancer centres. Internal Medicine Journal. 47(1). 75–81. 6 indexed citations

12.

Yu, Jun, Emilia Ip, Aileen Dela Peňa, et al.. (2006). COX‐2 induction in mice with experimental nutritional steatohepatitis. Hepatology. 43(4). 826–836. 146 indexed citations

13.

Ip, Emilia, Geoff Farrell, Pauline de la Μ. Hall, Graham Robertson, & Isabelle Leclercq. (2004). Administration of the potent PPARα agonist, Wy-14,643, reverses nutritional fibrosis and steatohepatitis in mice. Hepatology. 39(5). 1286–1296. 319 indexed citations

14.

Ip, Emilia, Geoffrey C. Farrell, Graham Robertson, et al.. (2003). Central Role of Pparα–Dependent Hepatic Lipid Turnover in Dietary Steatohepatitis in Mice. Hepatology. 38(1). 123–132. 417 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact